Category Archives: Inside BIO Industry Analysis

Maximize Your Savings Potential During BIO International Convention


$161,000,000 That’s how much BIO saved life science companies in aggregate on their 2014 purchases of products and services. More than 2,800 companies nationwide participate in the industry’s largest cost savings program known as BIO Business Solutions®, by taking advantage of the program’s preferential pricing and other benefits. Find out how your company can save money and become a partaker by stopping by the Member Services Pavilion at booth #2001 during the convention. BIO’s Member Services Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

13 Days Until BIO 2015: Moneyball: Acing the Big Pharma/Small Biotech Deal

BIO Business Networking

In just a few weeks, thousands of players in the pharma and biotech industry will converge on Philadelphia for BIO 2015 seeking knowledge, insight and, for many, the ultimate goal – new partnerships. Collaboration is often the key to success for emerging biotech companies and big pharma alike as it can open the door to new markets, influencers and revenue streams. In oncology, deals between established pharmaceutical companies and early-stage biotechs are especially relevant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

BIO’s Dave Thomas Talks VC Funding with Daniel Levine


Last week, BIO Industry Analysis’s Dave Thomas spoke with Daniel Levine for his weekly podcast, The Bio Report. Dave discussed BIO‘s Venture Funding of Therapeutic Innovation Report, of which he is the lead author. The report analyzes data from four venture capital databases – Thomson Reuters, BioCentury, Elsevier, and Evaluate Pharm – to investigate investor trends, examine investment in specific therapeutic areas and indications, and identify disease areas that might be struggling for early-stage venture Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Accepting Nominations for its Award Honoring One Outstanding Woman in Industrial Biotech


Today, BIO announced that it has officially extended its deadline for the Rosalind Franklin Award for Leadership in Industrial Biotechnology. In its second year, the BIO Rosalind Franklin Award was created to honor an outstanding woman in the field of industrial biotechnology and bioprocessing.  Rosalind Elsie Franklin (25 July 1920 – 16 April 1958) was a British biophysicist and X-ray crystallographer who made critical contributions to the understanding of the fine molecular structures of DNA (deoxyribonucleic acid), Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , ,

Nasdaq Social Bell: Twitter Strategies For Biotechs

Nasdaq Social Bell

Last week at the BIO CEO & Investor Conference in New York City, I had the pleasure of speaking with John Machiz and Brad Smith from Nasdaq at their headquarters in Times Square to discuss the social media activity that happened onsite during the event, what made the discussion of the event online so robust, and what biotech companies can do to increase their visibility on Twitter. View the video below, and get a recap of the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,